Adjuvant Treatment After Surgical Resection for Anaplastic Thyroid Cancer, Stage IVA or IVB (Resectable)

For patients with stage IVA or IVB anaplastic thyroid cancer where surgical resection with anticipated R0 or R1 margins is feasible, surgery is the first step — but not the last. Following resection, a structured adjuvant protocol applies to eligible patients to achieve locoregional disease control.

Clinical Scenario

Anaplastic thyroid cancer confined to stage IVA or IVB; tumor resectable with anticipated R0 or R1 margins; no evidence of distant metastatic disease; good performance status.

Clinical goal: Locoregional disease control.

Following Prior Treatment

The preceding step is surgical resection — total or near-total thyroidectomy with therapeutic lymph node dissection of the central and lateral neck compartments, targeting complete visible tumor removal with R0 or R1 margins. This adjuvant protocol defines what comes next for good performance status patients once resection is completed and no distant metastatic disease is present.

Treatment Approach (partial)

The protocol involves adjuvant radiotherapy to the operative bed and neck, delivered concurrently with a taxane-based chemotherapy regimen. Full agent selection, combinations, and timing are detailed in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1089/thy.2020.0944

For patients with confined (stage IVA/IVB) ATC in whom R0/R1 resection is anticipated, we strongly recommend surgical resection.
Following R0 or R1 resection, we recommend that good performance status patients with no evidence of metastatic disease who wish an aggressive approach should be offered standard fractionation IMRT with concurrent systemic therapy.
The use of cytotoxic chemotherapy involving a taxane (paclitaxel or docetaxel), administered with or without anthracyclines (doxorubicin) or platin (cisplatin or carboplatin), is recommended in patients treated with definitive-intention radiation.
Radiation therapy should begin no later than 6 weeks after surgery.
Most studies report survival only, but those reporting local control generally show improvement with multimodality treatment.

View source ↗